Global Commercialization Lead, SMA
Biogen
Summary
As the Global Commercialization Lead for SMA, you will play a pivotal role in shaping the commercialization strategy for this key therapeutic area within the Global Product Strategy and Commercialization team. This position entails developing a robust global commercialization strategy and leading the Global Marketing team to maximize brand value and achieve revenue targets.
Job description
What You’ll Do
- Develop and lead the global commercialization strategy across multiple regions.
- Own the short-term brand plan, focusing on revenue maximization and supporting annual revenue targets.
- Lead the Global Marketing team in delivering campaigns, messages, and marketing initiatives.
- Provide commercial input to long-term strategic decisions, including lifecycle management and asset value maximization.
- Partner with regions and affiliates to deliver on country-specific needs and optimize the asset value.
- Conduct competitive workshops and market assessments to inform strategic decisions.
- Engage with external stakeholders such as clinicians, policy stakeholders, and advocacy groups.
- Drive cross-functional alignment and collaboration across marketing, medical, and market access teams.
- Ensure launch planning, readiness, and execution are effectively managed.
- Operate within a Product Development & Commercialization model.
Who You Are
You are a strategic thinker with a deep understanding of global commercialization in the biotech or pharma industry. Your ability to lead and inspire cross-functional teams is matched by your expertise in navigating complex alliances and competitive landscapes. You thrive in a matrix environment, influencing without direct authority and driving alignment across diverse teams. Your strong communication skills and insights-driven approach enable you to craft cohesive strategies that address global and regional market dynamics effectively.
Requirements
- Bachelor’s degree in business, life sciences, or related discipline.
- 15+ years of experience in the pharma/biotech industry.
- Direct affiliate in-market experience required; 5 years ex-US experience required.
- Proven experience in biotech product launches.
- Strong P&L experience preferred.
- Therapeutic area experience in rare diseases, transplant, neuro, and immunology.
- Advanced degree such as MBA, MSc, or PhD preferred.
- Experience with strategic financial trajectory planning preferred.
- Background in engaging with external partners and stakeholders preferred.
Benefits
- Medical, Dental & Vision
- Life Insurance
- Fitness & Wellness Programs
- Short-Term Disability
- Long-Term Disability
- Paid Vacation
- Paid Holidays
- Sick Time
- Paid Maternity & Parental Leave
- 401(k) Matching
- Employee Stock Purchase Plan
- Tuition Reimbursement
- Employee Resource Groups
Company overview
Founded in 1978, Biogen is a leading global biotechnology company headquartered in Cambridge, Massachusetts, specializing in the development and commercialization of innovative therapies for serious neurological and neurodegenerative diseases. As one of the oldest independent biotechnology companies in the United States, Biogen has established itself as a pioneer in neuroscience, focusing on difficult-to-treat conditions where few or no treatment options exist. The company's portfolio includes groundbreaking treatments for multiple sclerosis, spinal muscular atrophy, Alzheimer's disease, ALS, and Friedreich's ataxia. With approximately 7,000 employees worldwide, Biogen operates through a global network that includes research and development hubs in Cambridge, Research Triangle Park in North Carolina, and South San Francisco, along with world-class manufacturing facilities in the United States and Switzerland. The company's commitment to scientific innovation is demonstrated by its Nobel Prize-winning founders and its receipt of the U.S. National Medal of Technology and Innovation. Biogen's patient-centric approach drives its mission to deliver transformative medicines that improve lives while creating sustainable value for shareholders and communities.